The gateway to everything entrepreneurial at Cornell University

Cornell Venture Capitalists

Zachary Shulman

ILR '87, JD '90

Managing Partner
Cayuga Venture Fund (Ithaca, NY)

Biography

Zachary Shulman, Managing Partner, joined CVF in August 2004. From January 1999 through March 2002, Zach served as General Counsel and Chief Investor Relations Officer of Spike Broadband Systems, where he was responsible for general oversight of Spike's legal functions, While at Spike, he was also responsible for operational tracking over Spike's functional business areas. While at Spike, Zach negotiated and closed over $80 million in venture capital financing.

Prior to joining Spike, Zach was an associate at the law firm of Harris Beach in Ithaca, New York. At Harris Beach, he focused his practice on representing private and public corporations in a wide range of capacities, including equity financing through private placements and venture capital, bank financing, mergers and acquisitions, and the establishment and implementation of corporate governance policies, including advising boards of directors and executive management with respect to such policies. Before Harris Beach, Zach was an associate at Ropes & Gray in Boston, Massachusetts, where he represented predominantly public companies in equity and debt offerings, commercial lending, Securities and Exchange Commission compliance, mergers and acquisitions and executive compensation matters.

Zach is also affiliated with Cornell's Johnson Graduate School of Management where he coordinates “Entrepreneurship@Johnson” and teaches law for high-growth businesses.

Education

He earned a Bachelor of Science from the Cornell University School of Industrial and Labor Relations and graduated from Cornell University Law School, magna cum laude.

Board Affiliations

Zach serves on the Industrial Advisory Board of the NYS Center for Life Science Enterprise at Cornell and on the Advisory Board of Cornell's Life Sciences Incubator initiative. He also currently serves as a Director of Primet Precision Materials, Advion BioSciences, Predict Systems and CherryPharm.